
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 1000+ patients with brain tumors.
Growth Trajectory
GT Medical Technologies is poised for growth through the expansion of GammaTile Centers and increased adoption by hospitals and medical centers, supported by $37 million in Series D funding. The company is also focusing on neurosurgical research and clinical innovation to advance brain tumor treatment and is actively recruiting for clinical trials, indicating a commitment to expanding treatment options.
Technical Challenges
Tech Stack
Team Size
Key Risks
Opportunities
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats